To further investigate if BMP4 can have a beneficial effect on tumor‐bearing bone it would be interesting to explore the effect of BMP4 gene therapy in a syngeneic myeloma mouse model, perhaps also in combination with anti‐resorptive treatment such as Denosumab or bisphosphonates. This evidence concerns the gene BMP4 and plasma cell myeloma.